Antigen-based immunotherapy (AIT) for autoimmune and allergic disease

Current Opinion in Pharmacology

Volumn 23, Issue , 2015, Pages 11-16

  Macleod, Megan Kl ^a   Anderton, Stephen M ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; GLYCOPROTEIN GP 39; PEPTIDE; PLACEBO; ANTIGEN;

ALLERGIC DISEASE; ANTIGEN BASED IMMUNOTHERAPY; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CONSENSUS; EFFECTOR CELL; EPIGENETICS; GENETIC TRANSCRIPTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; INFLAMMATION; MEMORY T LYMPHOCYTE; MURINE MODEL; NONHUMAN; PRIORITY JOURNAL; RODENT MODEL; T LYMPHOCYTE; ANIMAL; AUTOIMMUNE DISEASES; DESENSITIZATION; DRUG EFFECTS; HYPERSENSITIVITY; IMMUNOLOGY; PROCEDURES; TRENDS;

ANIMALS; ANTIGENS; AUTOIMMUNE DISEASES; DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY; IMMUNE TOLERANCE;

EID: 84930005877     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2015.05.003     Document Type: Review

References (40)

1. J.A. Collado, C. Guitart, M.T. Ciudad, I. Alvarez, and D. Jaraquemada The repertoires of peptides presented by MHC-II in the thymus and in peripheral tissue: a clue for autoimmunity? Front Immunol 4 2013 442
2. H. Bour-Jordan, J.H. Esensten, M. Martinez-Llordella, C. Penaranda, M. Stumpf, and J.A. Bluestone Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family Immunol Rev 241 2011 180 205
3. P. Chappert, and R.H. Schwartz Induction of T cell anergy: integration of environmental cues and infectious tolerance Curr Opin Immunol 22 2010 552 559
4. C.J. Gamper, and J.D. Powell Genetic and biochemical regulation of CD4 T cell effector differentiation: insights from examination of T cell clonal anergy Immunol Res 47 2010 162 171
5. C.B. Smarr, P.J. Bryce, and S.D. Miller Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases Crit Rev Immunol 33 2013 389 414
6. C.E. Smith, T.N. Eagar, J.L. Strominger, and S.D. Miller Differential induction of IgE-mediated anaphylaxis after soluble vs. cell-bound tolerogenic peptide therapy of autoimmune encephalomyelitis Proc Natl Acad Sci U S A 102 2005 9595 9600
7. J.N. Francis, L.K. James, G. Paraskevopoulos, C. Wong, M.A. Calderon, S.R. Durham, and S.J. Till Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity J Allergy Clin Immunol 121 2008 1120-1125.e1122
8. A. Wakkach, N. Fournier, V. Brun, J.P. Breittmayer, F. Cottrez, and H. Groux Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo Immunity 18 2003 605 617
9. E. Wambre, J.H. DeLong, E.A. James, N. Torres-Chinn, W. Pfutzner, C. Mobs, S.R. Durham, S.J. Till, D. Robinson, and W.W. Kwok Specific immunotherapy modifies allergen-specific CD4(+) T-cell responses in an epitope-dependent manner J Allergy Clin Immunol 133 2014 872-879.e877
10. A. Zaleska, T. Eiwegger, O. Soyer, W. van de Veen, C. Rhyner, M.B. Soyka, C. Bekpen, D. Demiroz, A. Treis, and S. Sollner Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccine Allergy 69 2014 1162 1170
11. H. Nelson, S. Cartier, F. Allen-Ramey, S. Lawton, and M.A. Calderon Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy J Allergy Clin Immunol Pract 2014
12. G. Senti, B.M. Prinz Vavricka, I. Erdmann, M.I. Diaz, R. Markus, S.J. McCormack, J.J. Simard, B. Wuthrich, R. Crameri, and N. Graf Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial Proc Natl Acad Sci U S A 105 2008 17908 17912
13. E.C. Tsark, W. Wang, Y.C. Teng, D. Arkfeld, G.R. Dodge, and S. Kovats Differential MHC class II-mediated presentation of rheumatoid arthritis autoantigens by human dendritic cells and macrophages J Immunol 169 2002 6625 6633
14. S. Blass, A. Union, J. Raymackers, F. Schumann, U. Ungethum, S. Muller-Steinbach, F. De Keyser, J.M. Engel, and G.R. Burmester The stress protein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis Arthritis Rheum 44 2001 761 771
15. S.C. Law, S. Street, C.H. Yu, C. Capini, S. Ramnoruth, H.J. Nel, E. van Gorp, C. Hyde, K. Lau, and H. Pahau T-cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles Arthritis Res Ther 14 2012 R118
16. M. Varrin-Doyer, A. Shetty, C.M. Spencer, U. Schulze-Topphoff, M.S. Weber, C.C. Bernard, T. Forsthuber, B.A. Cree, A.J. Slavin, and S.S. Zamvil MOG transmembrane and cytoplasmic domains contain highly stimulatory T-cell epitopes in MS Neurol Neuroimmunol Neuroinflamm 1 2014 e20
17. K.W. Wucherpfennig, A. Sette, S. Southwood, C. Oseroff, M. Matsui, J.L. Strominger, and D.A. Hafler Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones J Exp Med 179 1994 279 290
18. A. Elong Ngono, S. Pettre, M. Salou, B. Bahbouhi, J.P. Soulillou, S. Brouard, and D.A. Laplaud Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing-remitting multiple sclerosis patients Clin Immunol 144 2012 117 126
19. J. Yang, I.T. Chow, T. Sosinowski, N. Torres-Chinn, C.J. Greenbaum, E.A. James, J.W. Kappler, H.W. Davidson, and W.W. Kwok Autoreactive T cells specific for insulin B:11-23 recognize a low-affinity peptide register in human subjects with autoimmune diabetes Proc Natl Acad Sci U S A 111 2014 14840 14845
20. + T cells recognize diverse epitopes within GAD65: implications for repertoire development and diabetes monitoring Immunology 138 2013 269 279
21. C.L. Vanderlugt, and S.D. Miller Epitope spreading in immune-mediated diseases: implications for immunotherapy Nat Rev Immunol 2 2002 85 95
22. L.C. Harrison, J.M. Wentworth, Y. Zhang, E. Bandala-Sanchez, R.M. Bohmer, A.M. Neale, N.L. Stone, G. Naselli, J.J. Bosco, and P. Auyeung Antigen-based vaccination and prevention of type 1 diabetes Curr Diab Rep 13 2013 616 623
23. A. Lutterotti, and R. Martin Antigen-specific tolerization approaches in multiple sclerosis Expert Opin Investig Drugs 23 2014 9 20
24. E.C. Koffeman, M. Genovese, D. Amox, E. Keogh, E. Santana, E.L. Matteson, A. Kavanaugh, J.A. Molitor, M.H. Schiff, and J.O. Posever Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial Arthritis Rheum 60 2009 3207 3216
25. P.K. Gregersen, J. Silver, and R.J. Winchester The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis Arthritis Rheum 30 1987 1205 1213
26. R.B. Landewe, J.G. Houbiers, F. Van den Bosch, J. in't Hout, P.C. Verschueren, J.H. Meijerink, F.H. van den Hoogen, B.A. Masek, G.A. Bruyn, and J.M. Wouters Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trial Ann Rheum Dis 69 2010 1655 1659
27. C.M. Hilkens, and J.D. Isaacs Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now? Clin Exp Immunol 172 2013 148 157
28. N. Giannoukakis, B. Phillips, D. Finegold, J. Harnaha, and M. Trucco Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients Diabetes Care 34 2011 2026 2032
29. E. Martin, C. Capini, E. Duggan, V.P. Lutzky, P. Stumbles, A.R. Pettit, B. O'Sullivan, and R. Thomas Antigen-specific suppression of established arthritis in mice by dendritic cells deficient in NF-kappaB Arthritis Rheum 56 2007 2255 2266
30. J.N. Stoop, R.A. Harry, A. von Delwig, J.D. Isaacs, J.H. Robinson, and C.M. Hilkens Therapeutic effect of tolerogenic dendritic cells in established collagen-induced arthritis is associated with a reduction in Th17 responses Arthritis Rheum 62 2010 3656 3665
31. R.A. Maldonado, R.A. LaMothe, J.D. Ferrari, A.H. Zhang, R.J. Rossi, P.N. Kolte, A.P. Griset, C. O'Neil, D.H. Altreuter, and E. Browning Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance Proc Natl Acad Sci U S A 112 2015 E156 E165
32. Z. Hunter, D.P. McCarthy, W.T. Yap, C.T. Harp, D.R. Getts, L.D. Shea, and S.D. Miller A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease ACS Nano 8 2014 2148 2160
33. O. Snir, M. Rieck, J.A. Gebe, B.B. Yue, C.A. Rawlings, G. Nepom, V. Malmstrom, and J.H. Buckner Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1∗0401-positive humanized mice and rheumatoid arthritis patients Arthritis Rheum 63 2011 2873 2883
34. J.R. Podojil, and S.D. Miller Molecular mechanisms of T-cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy Immunol Rev 229 2009 337 355
35. B.R. Burton, G.J. Britton, H. Fang, J. Verhagen, B. Smithers, C.A. Sabatos-Peyton, L.J. Carney, J. Gough, S. Strobel, and D.C. Wraith Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy Nat Commun 5 2014 4741
36. J.E. Konkel, F. Frommer, M.D. Leech, H. Yagita, A. Waisman, and S.M. Anderton PD-1 signalling in CD4(+) T cells restrains their clonal expansion to an immunogenic stimulus, but is not critically required for peptide-induced tolerance Immunology 130 2010 92 102
37. M.K. MacLeod, E.T. Clambey, J.W. Kappler, and P. Marrack CD4 memory T cells: what are they and what can they do? Semin Immunol 21 2009 53 61
38. K.J. Mackenzie, D.J. Nowakowska, M.D. Leech, A.J. McFarlane, C. Wilson, P.M. Fitch, R.A. O'Connor, S.E. Howie, J. Schwarze, and S.M. Anderton Effector and central memory T helper 2 cells respond differently to peptide immunotherapy Proc Natl Acad Sci U S A 111 2014 E784 E793
39. A. David, F. Crawford, P. Garside, J.W. Kappler, P. Marrack, and M. MacLeod Tolerance induction in memory CD4 T cells requires two rounds of antigen-specific activation Proc Natl Acad Sci U S A 111 2014 7735 7740
40. R.C. McPherson, J.E. Konkel, C.T. Prendergast, J.P. Thomson, R. Ottaviano, M.D. Leech, O. Kay, S.E. Zandee, C.H. Sweenie, and D.C. Wraith Epigenetic modification of the PD-1 (Pdcd1) promoter in effector CD4(+) T cells tolerized by peptide immunotherapy Elife 4 2015